Quest Diagnostics Inc. (DGX) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Quest Diagnostics Inc. (DGX:NYSE), powered by AI.

Current Price
$201.04
P/E Ratio
22.5
Market Cap
22.3B
Sector
Healthcare
What is the Quest Diagnostics Inc. stock price forecast?

Quest Diagnostics Inc. is currently trading at $201.04. View real-time AI analysis on Alpha Lenz.

What is Quest Diagnostics Inc. insider trading activity?

View the latest insider trading data for Quest Diagnostics Inc. on Alpha Lenz.

What is Quest Diagnostics Inc.'s P/E ratio?

Quest Diagnostics Inc.'s P/E ratio is 22.5.

Quest Diagnostics Inc.

NYSE · DGX
$201.04-1.14(-0.56%)Pre-marketNYSE regular session 09:30–16:00 ET
Ask about Quest Diagnostics Inc.'s future dividend policy...
Alpha Chat Insight

Quest Diagnostics Inc. trades at a P/E of 22.5 (fair value) with solid ROE of 14.2%.

Ask for details

Company Overview

Quest Diagnostics Inc. is a leading healthcare company specializing in diagnostic information services, with a significant presence in the global diagnostics and research sector. The company provides laboratory testing services that are crucial for medical decision-making, serving physicians, hospitals, and patients. Quest Diagnostics processes one of the largest databases of de-identified clinical lab results worldwide, enabling it to deliver actionable diagnostic insights that support disease detection, treatment management, and overall healthcare quality. The company operates at scale, reportedly serving one in three adult Americans and partnering with over half of U.S. physicians and hospitals. Its offerings encompass a broad range of tests, including routine blood work, advanced genetic screenings, and specialized clinical testing. Quest Diagnostics plays a vital role in the healthcare ecosystem by empowering individuals and organizations with timely, reliable data that informs clinical practice and public health decisions. The company’s extensive reach, data-driven approach, and commitment to innovation reinforce its status as a foundational asset within the healthcare and diagnostic services market.

CEOMr. James E. Davis
SectorHealthcare
IndustryDiagnostics & Research
Employees55,000

Company Statistics

FY 2025

Profile

$22.32BMarket Cap
$11.04BRevenue
0.00Shares Out
55,000Employees

Margins

33.21%Gross
19.62%EBITDA
14.10%Operating
11.94%Pre-Tax
9.48%Net

Valuation

22.50P/E
3.11P/B
2.02EV/Sales
13.21EV/EBITDA
16.42P/FCF

Growth (CAGR)

3.74%Rev 3Yr
3.18%Rev 5Yr
2.90%Op Inc 3Yr
-4.62%Op Inc 5Yr
1.01%Net Inc 3Yr
-6.94%Net Inc 5Yr

Returns

6.46%ROA
14.22%ROE
9.85%ROIC

Financial Health

$420.00MCash & Cash Equivalents
$8.52BNet Debt
122.69%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Quest Diagnostics Inc. (ticker: DGX) is a company listed on NYSE in the Healthcare sector (Diagnostics & Research). It has approximately 55,000 employees. Market cap is $22.3B.

The current price is $201.04 with a P/E ratio of 22.5x and P/B of 3.11x.

ROE is 14.22% and operating margin is 14.10%. Annual revenue is $11.0B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Quest Diagnostics Inc. (DGX) Stock Forecast 2026 $201.04 — Price, Financials & Analyst Targets | Alpha Lenz